Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Shares of Centene Corp. CNC, +2.95% fell 3% in premarket trading on Wednesday after the company said it will cover the cost of COVID-19-related screening, testing, and for people who have its Medicare, Medicaid and health insurance exchange plans.

Centene to cover cost of COVID-19 care for Medicare, Medicaid patients

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

Centene (CNC) Down 5.5% Since Last Earnings Report: Can It Rebound?

The IBD SmartSelect Composite Rating for Centene rose from 88 to 96 Thursday. 
The post Highly Rated Centene Stock Joins An Elite List appeared first on Investor's Business Daily.

Highly Rated Centene Stock Joins An Elite List

Centene (CNC) updates its 2020 outlook that reflects its WellCare buyout and the potential Medicaid rate decrease.

Centene (CNC) Reduces 2020 Earnings Estimates, Shares Slide

Centene Corp. CNC, -2.54% shares fell 3.8% in the extended session Tuesday after the health-care manager tweaked its guidance for 2020 to reflect an acquisition and said it could face a rate reduction.

Centene tweaks 2020 guidance, warns of potential rate decrease

Anthem

HCA Healthcare

Molina Healthcare

Tenet Healthcare

UnitedHealth Group

Disparity in the regulatory policies of presidential candidates of various parties renders volatility to the healthcare sector.

Healthcare Sector to Remain Volatile in 2020 Amid Elections

A Relative Strength Rating upgrade for Centene shows improving technical performance.
The post Centene Clears Technical Benchmark, Hitting 80-Plus RS Rating appeared first on Investor's Business Daily.

Centene Clears Technical Benchmark, Hitting 80-Plus RS Rating

Health insurer Centene will be on the lookout for potential acquisitions after integrating its biggest-ever purchase in WellCare Health Plans.

Centene’s ‘Insatiable Appetite’ For Deals Remains After WellCare Purchase

Centene Corporation (CNC) CEO Michael Neidorff on Q4 2019 Results - Earnings Call Transcript

The managed-healthcare company beat Wall Street's revenue estimate, but its earnings declined year over year.

What's Behind Centene's Solid but Unspectacular Q4 Earnings Results

Centene's (CNC) fourth-quarter results gain traction from better revenues.

Centene's (CNC) Q4 Earnings Miss Estimates, Improve Y/Y

Health insurer Centene said the addition of WellCare Health Plans means the company now serves “1 in every 15 Americans” as a national provider of government-sponsored healthcare including Obamacare.

Centene CEO: We’re Now A $100 Billion-Plus Enterprise

Centene (CNC) delivered earnings and revenue surprises of -1.35% and 2.19%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Centene (CNC) Q4 Earnings Miss Estimates

Centene's (CNC) Q4 earnings results are likely to reflect membership growth and better revenues.

What's in the Cards for Centene's (CNC) Earnings in Q4?

Cigna

Humana

A Bernie Sanders surge in the polls and the spreading coronavirus suddenly have UnitedHealth and other health care stocks looking ill.

Why UnitedHealth And Other Health Care Stocks Are Suddenly Looking ill

CVS Health

iShares U.S. Healthcare Providers ETF

The iShares U.S. Healthcare Providers ETF (NYSEArca: IHF) scuffled through much of 2019 before gaining some momentum in the fourth quarter.

A Strong Start to 2020 For This Healthcare ETF

WellCare Health Plans

The two companies have received all clearances necessary to complete their $17 billion-plus deal.

Centene and WellCare Merger Approved by Regulators

Let's see if Centene Corporation (CNC) stock is a good choice for value-oriented investors right now from multiple angles.

Is Centene Corporation (CNC) a Good Value Investor Pick Now?

Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Centene (CNC) Beat Estimates Again in Its Next Earnings Report?

Biogen

Zoetis

These are the health care stocks with the best value, fastest growth, and most momentum for January.

Top Health Care Stocks for January 2020

Centene: A Compelling Risk-Reward

Centene (CNC) closed the most recent trading day at $61.93, moving +0.1% from the previous trading session.

Centene (CNC) Gains But Lags Market: What You Should Know

The IBD SmartSelect Composite Rating for Centene increased from 92 to 97 Thursday. 
The post Top-Rated Stocks: Centene Sees Composite Rating Climb To 97 appeared first on Investor's Business Daily.

Top-Rated Stocks: Centene Sees Composite Rating Climb To 97

In the latest trading session, Centene (CNC) closed at $58.64, marking a -1.64% move from the previous day.

Centene (CNC) Stock Sinks As Market Gains: What You Should Know

Apple

Delta Air Lines

DuPont de Nemours

Hewlett Packard

LyondellBasell Industries

Rio Tinto plc Sponsored

United Continental Hlds

Even as the market soars to new record highs, these stocks still have significant upside potential, per research by Bernstein.

News for Centene Stock (CNC)